In a previous study, we found that IL-1β released by NSCLC cells activates NF-κB and, thus, suppresses the expression of miR-22-3p (miR-22) in HDMECs co-cultured with NSCLC cells. This evidence concerns the gene IL1B and non-small cell lung carcinoma.